Bridgeport, CT: Cannabis treatment significantly reduces symptoms in patients with refractory gastroparesis, according to clinical…
Region: CT
Hartford, CT: State regulators have moved to expand the pool of patients eligible to receive…
Sickle cell disease (SCD) patients who utilize medicinal cannabis require fewer hospitalizations as compared to SCD patients who refrain from the substance.
Governor-elect Ned Lamont reaffirmed his support for regulating the adult use cannabis market in Connecticut.
A federal judge for the US District Court of Connecticut has ruled that an employer engaged in discrimination by rescinding a job offer to an employee solely based on her status as a medical cannabis patient.
Patients with severe rheumatoid arthritis, spasticity disorders, and neuropathic facial pain are among those who are now eligible for marijuana therapy following a decision this week by regulators to expand the program’s list of qualifying conditions.
Medical cannabis use is relatively common among patients with sickle cell disease, according to survey data published in the journal Cannabis and Cannabinoid Research.
Ninety-two percent of respondents reported their “willingness to help children with cancer access medical marijuana.”